Cargando…
A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use
Cocaine, one of most prevalent illicit substances in the United States, affects a multitude of organ systems and precedes numerous negative health outcomes. Many of the consequences of cocaine are linked to induction of vasoconstriction. For this reason, cocaine users are placed at considerable risk...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201179/ https://www.ncbi.nlm.nih.gov/pubmed/37209041 http://dx.doi.org/10.1177/23247096231176215 |
_version_ | 1785045215261753344 |
---|---|
author | Jaenke, Chad M. Moore, Sara R. Miller, Matthew D. Garg, Anu |
author_facet | Jaenke, Chad M. Moore, Sara R. Miller, Matthew D. Garg, Anu |
author_sort | Jaenke, Chad M. |
collection | PubMed |
description | Cocaine, one of most prevalent illicit substances in the United States, affects a multitude of organ systems and precedes numerous negative health outcomes. Many of the consequences of cocaine are linked to induction of vasoconstriction. For this reason, cocaine users are placed at considerable risk of ischemic stroke, myocardial infarction, and cardiac arrhythmias. Furthermore, a prominent contaminant, levamisole, has been widely implicated in predisposing individuals to developing or exacerbating cutaneous vasculitides. This report details a 31-year-old woman with acute, localized necrotic skin lesions after cocaine use. Her clinical picture was complicated by a 17-year history of systemic lupus erythematosus (SLE) and Raynaud’s phenomenon. This case examines the challenge of forming a differential diagnosis, initiating an appropriate workup, and interpreting serologic-based and immunologic-based studies to differentiate between SLE and drug-based etiologies of skin necrosis. Finally, we discuss appropriate treatment plans to mitigate symptoms and reduce future instances of drug-induced vasculitis. |
format | Online Article Text |
id | pubmed-10201179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-102011792023-05-23 A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use Jaenke, Chad M. Moore, Sara R. Miller, Matthew D. Garg, Anu J Investig Med High Impact Case Rep Case Report Cocaine, one of most prevalent illicit substances in the United States, affects a multitude of organ systems and precedes numerous negative health outcomes. Many of the consequences of cocaine are linked to induction of vasoconstriction. For this reason, cocaine users are placed at considerable risk of ischemic stroke, myocardial infarction, and cardiac arrhythmias. Furthermore, a prominent contaminant, levamisole, has been widely implicated in predisposing individuals to developing or exacerbating cutaneous vasculitides. This report details a 31-year-old woman with acute, localized necrotic skin lesions after cocaine use. Her clinical picture was complicated by a 17-year history of systemic lupus erythematosus (SLE) and Raynaud’s phenomenon. This case examines the challenge of forming a differential diagnosis, initiating an appropriate workup, and interpreting serologic-based and immunologic-based studies to differentiate between SLE and drug-based etiologies of skin necrosis. Finally, we discuss appropriate treatment plans to mitigate symptoms and reduce future instances of drug-induced vasculitis. SAGE Publications 2023-05-20 /pmc/articles/PMC10201179/ /pubmed/37209041 http://dx.doi.org/10.1177/23247096231176215 Text en © 2023 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Jaenke, Chad M. Moore, Sara R. Miller, Matthew D. Garg, Anu A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use |
title | A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus
Erythematosus and Cocaine Use |
title_full | A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus
Erythematosus and Cocaine Use |
title_fullStr | A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus
Erythematosus and Cocaine Use |
title_full_unstemmed | A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus
Erythematosus and Cocaine Use |
title_short | A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus
Erythematosus and Cocaine Use |
title_sort | case of cutaneous vasculitis in the setting of systemic lupus
erythematosus and cocaine use |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201179/ https://www.ncbi.nlm.nih.gov/pubmed/37209041 http://dx.doi.org/10.1177/23247096231176215 |
work_keys_str_mv | AT jaenkechadm acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT mooresarar acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT millermatthewd acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT garganu acaseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT jaenkechadm caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT mooresarar caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT millermatthewd caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse AT garganu caseofcutaneousvasculitisinthesettingofsystemiclupuserythematosusandcocaineuse |